The Escherichia coli expression system remains the first choice for the production of recombinant proteins when biological activity is not compromised by posttranslational modification. Many strains of E. coli, vectors and culture conditions are available to express recombinant proteins in a soluble and correctly folded conformation. Often these strategies fail, and misfolded recombinant proteins aggregate into inclusion bodies. To recover its biological activity, a recombinant protein must be refolded, a step that has become the major limitation of the E. coli expression system. Chromatographic refolding, assisted by immobilized chaperones and foldases, is an in vitro refolding protocol that significantly improves refolding yields, yet its application at the bioprocess scale has been limited. Therefore, new cost-efficient alternatives to utilize chromatographic refolding assisted by chaperones and foldases might improve the production of biologically active proteins in E. coli. In this work, the GroEL apical domain (AD) and the oxidoreductases DsbA and DsbC fused to a carbohydrate-binding module (CBM) were purified and immobilized on microcrystalline cellulose particles. A column packed with a 60:40 (v/v) mixture of gel filtration media and cellulose particles with immobilized AD significantly improved the chromatographic refolding of rhodanese. A similar column with equimolar amounts of AD, DsbA and DsbC immobilized on cellulose particles significantly improved the oxidative chromatographic refolding of lysozyme. The assisted refolding yields were up to 80% for rhodanese and 100% for lysozyme, compared with 33% and 23%, respectively, obtained in the experiments without immobilized chaperones. In addition, AD, DsbA and DsbC immobilized on cellulose exhibited significant operational stability under the extreme denaturing conditions used in the chromatographic refolding batches. These results suggest that chromatographic refolding assisted by AD, DsbA, and DsbC immobilized on cellulose is suitable for the oxidative refolding of proteins expressed in E. coli as inclusion bodies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.chroma.2012.05.086 | DOI Listing |
Int J Mol Sci
December 2024
Dompé Farmaceutici S.p.A., Via Campo di Pile, Nucleo Industriale Pile, 67100 L'Aquila, Italy.
Thus far, no manufacturing process able to support industrialization has been reported for the recombinant human brain-derived neurotrophic factor (rhBDNF). Here, we described the setup of a new protocol for its production in () and its purification to homogeneity. A synthetic gene, codifying for the neurotrophin precursor, was inserted into an expression vector and transformed into BL21 (DE3) strain.
View Article and Find Full Text PDFProtein Expr Purif
March 2025
Biochemical Sciences Division, CSIR-National Chemical Laboratory, Pune, 411008, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India. Electronic address:
Insulin is a pivotal peptide hormone essential for regulating glucose homeostasis. It has been known for over 100 years, but its production and purification methods are still under improvement. Escherichia coli based bacterial expression system is primarily used for insulin production.
View Article and Find Full Text PDFJ Sep Sci
July 2024
Department of Biotechnology, Indian Institute of Technology Madras, Chennai, India.
Hydroxyapatite (HAp) is a calcium phosphate ceramic, widely used as a matrix for protein chromatography. The crystal structure of HAp is amenable to a wide range of substitutions, thus allowing for the alteration of its properties. In this study, nickel-ion substituted HAp (NiSHAp) was synthesized using a wet-precipitation method, followed by spray drying.
View Article and Find Full Text PDFInt Arch Allergy Immunol
December 2024
Research Division of Clinical Pharmacology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Biotechnol J
May 2024
Department of Physiology, University of Ulsan College of Medicine, Seoul, South Korea.
Human interleukin-3 (IL3) is a multifunctional cytokine essential for both clinical and biomedical research endeavors. However, its production in Escherichia coli has historically been challenging due to its aggregation into inclusion bodies, requiring intricate solubilization and refolding procedures. This study introduces an innovative approach employing two chaperone proteins, maltose binding protein (MBP) and protein disulfide isomerase b'a' domain (PDIb'a'), as N-terminal fusion tags.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!